We are live on ! Find out more
RP

Riverwater Partners Portfolio holdings

AUM $300M
1-Year Est. Return 26.4%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+26.4%
3 Year Est. Return
+85.45%
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
+$4.07M
Cap. Flow
+$3.06M
Cap. Flow %
1.49%
Top 10 Hldgs %
26.23%
Holding
235
New
29
Increased
97
Reduced
65
Closed
23

Sector Composition

Rank Sector Weight
1 Financials 16.75%
2 Technology 14.11%
3 Healthcare 11.23%
4 Industrials 9.56%
5 Consumer Staples 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
226
Northern Trust
NTRS
$21.8B
-2,317
Closed -$205K
OMC icon
227
Omnicom Group
OMC
$23.5B
-4,345
Closed -$443K
QCOM icon
228
Qualcomm
QCOM
$164B
-1,553
Closed -$261K
TCMD icon
229
Tactile Systems Technology
TCMD
$618M
-21,813
Closed -$311K
THG icon
230
Hanover Insurance
THG
$8.13B
-11,130
Closed -$1.64M
THRY icon
231
Thryv Holdings
THRY
$184M
-11,670
Closed -$207K
TKR icon
232
Timken Company
TKR
$9.19B
-2,444
Closed -$202K
TLH icon
233
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
-5,570
Closed -$607K
TLT icon
234
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
-2,364
Closed -$231K
TTGT icon
235
TechTarget
TTGT
$327M
-9,686
Closed -$232K

Similar funds

Riverwater Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Riverwater Partners held 235 positions worth $206M, up 2% from $201M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Riverwater Partners's Q4 2024 filing shows 29 new, 97 increased, 65 reduced and 23 closed positions. Its largest new stake was Exelixis: 57,444 shares worth $1.91M. The largest sale was Anika Therapeutics, an estimated $2.55M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Riverwater Partners's largest Q4 2024 buy was Exelixis: 57,444 shares worth $1.91M.
  • Riverwater Partners added most to Limoneira in Q4 2024, an estimated $1.49M increase.
  • Riverwater Partners's biggest Q4 2024 reduction was ICF International, cutting an estimated $1.79M.
  • Riverwater Partners fully exited Anika Therapeutics in Q4 2024, selling an estimated $2.55M.
  • Riverwater Partners's ten largest holdings make up 26% of its $206M portfolio in Q4 2024.
  • Riverwater Partners opened 29 new positions and closed 23 in Q4 2024.
  • Riverwater Partners's portfolio value rose 2% quarter-over-quarter to $206M.

Based on Riverwater Partners's 13F filing for Q4 2024, filed 13 Feb 2025.